drugset / Trial / NCT01364688
Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
Active vitamin D at therapeutic dose may prevent vascular calcification but in supraphysiologic dose may precipitate it.
Timeline
- Start
- 2011-05
- Primary completion
- 2012-11
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alfacalcidol | Other / unclassified | 0.5 ug | Oral |